Bioregenx BRGX
OTC BRGX
$0.01 +0.00 (+0.00%)
At close: Sep 18, 2026 · 4:00 PM EDT

Bioregenx (BRGX) Cash & Equivalents Growth (3y) (2024 - 2025)

Analysis

Bioregenx (BRGX) Cash & Equivalents Growth (3y) (2024 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. Growth (3y) (Qtr)
1 Abbott Laboratories 177.43 Bn 172.48 Bn 7.27 Bn -13.31%
2 Intuitive Surgical 139.20 Bn 134.11 Bn 1.96 Bn -7.03%
3 Medtronic 118.01 Bn 109.81 Bn 6.34 Bn 8.09%
4 Stryker 105.44 Bn 101.96 Bn 4.50 Bn 34.27%
5 Boston Scientific 62.90 Bn 62.60 Bn 3.85 Bn 8.16%
6 Edwards Lifesciences 50.87 Bn 46.72 Bn 1.35 Bn 40.74%
7 Dexcom 33.72 Bn 31.77 Bn 830.00 Mn -2.57%
8 Resmed 32.45 Bn 30.98 Bn 861.22 Mn 86.12%
9 Alcon 31.70 Bn 30.25 Bn 1.68 Bn 27.03%
10 Bioregenx 9.72 Mn 9.67 Mn 348,288.00 -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 368.20%
Sep 30, 2025 212.32%
Jun 30, 2025 179.70%
Mar 31, 2025 189.74%
Dec 31, 2024 33.84%
API Access

Bioregenx Cash & Equivalents Growth (3y) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-equivalents-growth-3y&ticker=BRGX&period=max&api_key=YOUR_API_KEY